<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR522.html">Part 522
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 522.956  Florfenicol and flunixin.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications. Each milliliter (mL) of solution contains 300  milligrams (mg) florfenicol and 16.5 mg flunixin (27.37 mg flunixin  meglumine).</p><p class="depth1"><em>(b)</em> Sponsor. See No. 000061 in Sec. 510.600(c) of this chapter for  use as in paragraph (d) of this section.</p><p class="depth1"><em>(c)</em> Tolerances. See Sec. Sec. 556.283 and 556.286 of this chapter.</p><p class="depth1"><em>(d)</em> Conditions for use in cattle--</p><p class="depth2"><em>(1)</em> Amount. 40 mg florfenicol/kg  body weight (BW) and 2.2 mg flunixin/kg BW (equivalent to 2 mL/15 kg BW  or 6 mL/100 lbs) once, by subcutaneous injection.</p><p class="depth2"><em>(2)</em> Indications for use. For treatment of bovine respiratory disease  (BRD) associated with Mannheimia haemolytica, Pasteurella multocida,  Histophilus somni, and Mycoplasma bovis, and control of BRD-associated  pyrexia in beef and non-lactating dairy cattle.</p><p class="depth2"><em>(3)</em> Limitations. Animals intended for human consumption must not be  slaughtered within 38 days of treatment. This drug product is not  approved for use in female dairy cattle 20 months of age or older,  including dry dairy cows. Use in these cattle may cause drug residues in  milk and/or in calves born to these cows. A withdrawal period has not  been established in preruminating calves. Do not use in calves to be  processed for veal. Federal law restricts this drug to use by or on the  order of a licensed veterinarian.  [75 FR 1275, Jan. 11, 2010, as amended at 75 FR 54018, Sept. 3, 2010; 79  FR 18158, Apr. 1, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
